Home » Topics » Medical technology

Medical technology
RSS

Guilford, Amgen Come Up Short In Phase II Parkinson¿s Study

July 27, 2001

NewBiotics Raises $11M In Series C Round For Programs

July 27, 2001

ViaCell Acquires Cerebrotec, Forms Neuroscience Division

July 26, 2001

Other News To Note

July 26, 2001

Medarex, HGS Sign UltiMAb Deal For Undisclosed Areas

July 26, 2001

Correction

July 26, 2001

Amylin Faces Uphill Fight; Aviron Poised For Approval

July 26, 2001

OSI, Genentech Start Phase III Program Of Tarceva In Cancer

July 26, 2001

Synthetic Antibiotics Nature Never Saw Work Well In Mice With Hope For Long-Stalled Drug Resistance

July 26, 2001

Australian Neuroscience Group Gets Funding From Schering AG

July 25, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...